Stifel Financial’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-51,139
| Closed | -$5.19M | – | 3675 |
|
|
2025
Q4 | $5.19M | Sell |
51,139
-1,051
| -2% | -$84.4K | ﹤0.01% | 1312 |
|
|
2025
Q3 | $2.86M | Sell |
52,190
-19,979
| -28% | -$998K | ﹤0.01% | 1646 |
|
|
2025
Q2 | $3.84M | Sell |
72,169
-607
| -0.8% | -$30.8K | ﹤0.01% | 1399 |
|
|
2025
Q1 | $3.15M | Buy |
72,776
+4,017
| +6% | +$203K | ﹤0.01% | 1449 |
|
|
2024
Q4 | $3.86M | Sell |
68,759
-12,202
| -15% | -$759K | ﹤0.01% | 1347 |
|
|
2024
Q3 | $5.51M | Buy |
80,961
+1,825
| +2% | +$103K | 0.01% | 1153 |
|
|
2024
Q2 | $3.34M | Sell |
79,136
-12,346
| -13% | -$679K | ﹤0.01% | 1377 |
|
|
2024
Q1 | $6.32M | Sell |
91,482
-837
| -0.9% | -$52.9K | 0.01% | 1018 |
|
|
2023
Q4 | $6.83M | Buy |
92,319
+32,425
| +54% | +$2.13M | 0.01% | 946 |
|
|
2023
Q3 | $4.09M | Buy |
59,894
+4,562
| +8% | +$387K | 0.01% | 1140 |
|
|
2023
Q2 | $5.2M | Buy |
55,332
+3,374
| +6% | +$263K | 0.01% | 1015 |
|
|
2023
Q1 | $3.52M | Sell |
51,958
-2,879
| -5% | -$185K | 0.01% | 1225 |
|
|
2022
Q4 | $2.72M | Sell |
54,837
-4,501
| -8% | -$184K | ﹤0.01% | 1303 |
|
|
2022
Q3 | $1.93M | Buy |
59,338
+1,958
| +3% | +$80.7K | ﹤0.01% | 1503 |
|
|
2022
Q2 | $2.26M | Sell |
57,380
-426
| -0.7% | -$22.8K | ﹤0.01% | 1418 |
|
|
2022
Q1 | $4.04M | Buy |
57,806
+9,858
| +21% | +$721K | 0.01% | 1172 |
|
|
2021
Q4 | $3.73M | Sell |
47,948
-5,117
| -10% | -$452K | ﹤0.01% | 1228 |
|
|
2021
Q3 | $5.07M | Sell |
53,065
-53,020
| -50% | -$5.6M | 0.01% | 1010 |
|
|
2021
Q2 | $13.2M | Buy |
106,085
+6,290
| +6% | +$751K | 0.02% | 611 |
|
|
2021
Q1 | $13.2M | Buy |
99,795
+4,925
| +5% | +$674K | 0.02% | 571 |
|
|
2020
Q4 | $12.6M | Buy |
94,870
+3,424
| +4% | +$414K | 0.02% | 527 |
|
|
2020
Q3 | $9.32M | Sell |
91,446
-12,097
| -12% | -$1.04M | 0.02% | 559 |
|
|
2020
Q2 | $9M | Buy |
103,543
+39,449
| +62% | +$3.15M | 0.02% | 531 |
|
|
2020
Q1 | $3.72M | Buy |
64,094
+3,988
| +7% | +$324K | 0.01% | 773 |
|
|
2019
Q4 | $5.54M | Buy |
60,106
+20,440
| +52% | +$1.8M | 0.01% | 845 |
|
|
2019
Q3 | $3.57M | Buy |
39,666
+7,423
| +23% | +$846K | 0.01% | 979 |
|
|
2019
Q2 | $3.81M | Buy |
32,243
+7,593
| +31% | +$765K | 0.01% | 972 |
|
|
2019
Q1 | $2.13M | Buy |
24,650
+2,247
| +10% | +$191K | 0.01% | 1206 |
|
|
2018
Q4 | $1.42M | Sell |
22,403
-6,771
| -23% | -$465K | ﹤0.01% | 1339 |
|
|
2018
Q3 | $2.3M | Buy |
29,174
+13,268
| +83% | +$865K | 0.01% | 1182 |
|
|
2018
Q2 | $952K | Sell |
15,906
-389
| -2% | -$20.9K | ﹤0.01% | 1649 |
|
|
2018
Q1 | $656K | Sell |
16,295
-1,141
| -7% | -$55.7K | ﹤0.01% | 1816 |
|
|
2017
Q4 | $916K | Sell |
17,436
-359
| -2% | -$19.2K | ﹤0.01% | 1578 |
|
|
2017
Q3 | $834K | Sell |
17,795
-7,228
| -29% | -$291K | ﹤0.01% | 1587 |
|
|
2017
Q2 | $888K | Buy |
25,023
+3,548
| +17% | +$110K | ﹤0.01% | 1534 |
|
|
2017
Q1 | $506K | Buy |
21,475
+310
| +1% | +$6.14K | ﹤0.01% | 1804 |
|
|
2016
Q4 | $282K | Buy |
21,165
+9,300
| +78% | +$150K | ﹤0.01% | 2069 |
|
|
2016
Q3 | $222K | Sell |
11,865
-8,650
| -42% | -$152K | ﹤0.01% | 2123 |
|
|
2016
Q2 | $252K | Buy |
20,515
+7,015
| +52% | +$52.8K | ﹤0.01% | 2141 |
|
|
2016
Q1 | $91K | Buy |
13,500
+1,974
| +17% | +$12.6K | ﹤0.01% | 2118 |
|
|
2015
Q4 | $106K | Buy |
+11,526
| New | +$107K | ﹤0.01% | 2229 |
|
|
2015
Q3 | – | Sell |
-7,600
| Closed | -$226K | – | 2285 |
|
|
2015
Q2 | $226K | Buy |
+7,600
| New | +$191K | ﹤0.01% | 2107 |
|
|
2015
Q1 | – | Sell |
-8,835
| Closed | -$242K | – | 2329 |
|
|
2014
Q4 | $242K | Buy |
+8,835
| New | +$215K | ﹤0.01% | 1973 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Stifel Financial's EXAS Position: Q1 2026 in Review
Stifel Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 51,139 shares — an estimated $5.19M sold.
Stifel Financial first reported a position in EXAS in Q4 2014 and held it in 43 quarters. The position peaked at $13.2M in Q2 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Stifel Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Stifel Financial sold 51,139 Exact Sciences shares in Q1 2026, an estimated $5.19M.
- Stifel Financial first reported a position in Exact Sciences in Q4 2014 and held it in 43 quarters.
- Stifel Financial's Exact Sciences position peaked at $13.2M in Q2 2021.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.